Boulder, Colorado--(Newsfile Corp. - May 11, 2021) - Auddia Inc.(NASDAQ: AUUD) today announced that Jeff Thramann, Founder and Executive Chairman will be attending the Q2 Virtual Investor Summit.  Event  Q2 Investor Summit  Date  May 17-18th, 2021  Presentation  May 18th at 2:00 PM ET  Location  https://zoom.us/webinar/register/WN_iKAceIBgQ6y0MUINe3i5lg   About Auddia Inc. About Auddia Inc.Auddia… Read More..

Honors for Highest Scoring Poster Abstract in Case Series/Study Category Confirms Commercialization Opportunities for AC5® Advanced Wound System FRAMINGHAM, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, presents two clinical case reports supporting… Read More..

PRINCETON, N.J., May 10, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that HyBryte™ (hypericin) was awarded an "Innovation Passport" for the treatment of early stage cutaneous… Read More..